HCW-9206

N/A

Report date: 2025/09/23 10:10:33

Base Information

Drug NameHCW-9206
Drug Alias NameHCW-9206
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukins replacementsInterleukin-15 replacementsInterleukin-7 replacements
TargetsInterleukinsInterleukin-15Interleukin-7
Therapy Area/IndicationsSolid tumoursLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHCW Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHCW Biologics IncWugen Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A